SE508043C2 - Förfarande för framställning och användning av 2-amino-2,4,4- trimetylpentansaltet av klavulansyra som mellanprodukt vid framställning av farmaceutiskt godtagbara salter av klavulansyra - Google Patents

Förfarande för framställning och användning av 2-amino-2,4,4- trimetylpentansaltet av klavulansyra som mellanprodukt vid framställning av farmaceutiskt godtagbara salter av klavulansyra

Info

Publication number
SE508043C2
SE508043C2 SE9300758A SE9300758A SE508043C2 SE 508043 C2 SE508043 C2 SE 508043C2 SE 9300758 A SE9300758 A SE 9300758A SE 9300758 A SE9300758 A SE 9300758A SE 508043 C2 SE508043 C2 SE 508043C2
Authority
SE
Sweden
Prior art keywords
clavulanic acid
salt
amino
pharmaceutically acceptable
trimethylpentane
Prior art date
Application number
SE9300758A
Other languages
English (en)
Swedish (sv)
Other versions
SE9300758L (sv
SE9300758D0 (sv
Inventor
Franz Krenmueller
Harald Summer
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of SE9300758D0 publication Critical patent/SE9300758D0/xx
Publication of SE9300758L publication Critical patent/SE9300758L/xx
Publication of SE508043C2 publication Critical patent/SE508043C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
SE9300758A 1992-03-10 1993-03-08 Förfarande för framställning och användning av 2-amino-2,4,4- trimetylpentansaltet av klavulansyra som mellanprodukt vid framställning av farmaceutiskt godtagbara salter av klavulansyra SE508043C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0047292A AT400033B (de) 1992-03-10 1992-03-10 Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben

Publications (3)

Publication Number Publication Date
SE9300758D0 SE9300758D0 (sv) 1993-03-08
SE9300758L SE9300758L (sv) 1993-09-11
SE508043C2 true SE508043C2 (sv) 1998-08-17

Family

ID=3491521

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9300758A SE508043C2 (sv) 1992-03-10 1993-03-08 Förfarande för framställning och användning av 2-amino-2,4,4- trimetylpentansaltet av klavulansyra som mellanprodukt vid framställning av farmaceutiskt godtagbara salter av klavulansyra

Country Status (21)

Country Link
US (4) US20010036940A1 (zh)
JP (2) JP2817563B2 (zh)
CN (3) CN1045604C (zh)
AT (1) AT400033B (zh)
AU (1) AU659282B2 (zh)
CH (1) CH685054A5 (zh)
CY (1) CY1995A (zh)
DE (1) DE4307422B4 (zh)
DK (1) DK26093A (zh)
ES (1) ES2058029B1 (zh)
FI (1) FI101965B (zh)
FR (1) FR2688506B1 (zh)
GB (1) GB2264944B (zh)
GR (1) GR1002329B (zh)
HK (1) HK42696A (zh)
IE (1) IE70926B1 (zh)
IT (1) IT1261213B (zh)
NL (1) NL9300430A (zh)
NO (1) NO301372B1 (zh)
SE (1) SE508043C2 (zh)
TW (1) TW364907B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
DE69427312T2 (de) 1993-11-17 2001-08-23 Biochemie Ges.M.B.H., Kundl Trennung von Cephalosporinisomeren
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
DE69618045D1 (de) * 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
CN1312814A (zh) * 1998-07-16 2001-09-12 Dsm公司 制备棒酸盐类及其酯类的改进方法
ATE260096T1 (de) * 1999-04-01 2004-03-15 Dsm Ip Assets Bv Agglomerate durch kristallisation
US7767823B2 (en) * 2000-05-13 2010-08-03 Smithkline Beecham Limited Process for the purification of a salt of clavulanic acid
KR20090004839A (ko) * 2005-09-07 2009-01-12 제네렉스, 인코포레이티드 Ｇｍ-ｃｓｆ를 발현하는 폭스바이러스를 사용한 전이성및/또는 전신 파종성 암의 전신 치료법
JP7028064B2 (ja) 2018-05-30 2022-03-02 横河電機株式会社 機器保全装置、機器保全方法、機器保全プログラム及び記録媒体
EP4178710A1 (en) 2020-07-10 2023-05-17 Carbon Clean Solutions Limited A method and system for the removal of carbon dioxide from solvents using low-grade heat

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288800A (en) 1962-05-29 1966-11-29 Squibb & Sons Inc Schiff's bases of 6-amino-penicillanic acid and purification of 6-aminopenicillanic acid by the use thereof
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
IE41109B1 (en) 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
US4110165A (en) 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
GB1543563A (en) 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
US4144242A (en) 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB1561395A (en) 1976-02-26 1980-02-20 Beecham Group Ltd -lactam antibiotic
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB2003863B (en) 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
DE2861607D1 (en) 1977-11-26 1982-03-11 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
NZ213963A (en) 1984-10-27 1989-01-06 Antibioticos Sa Production of clavulanic acid
GB8618888D0 (en) 1986-08-01 1986-09-10 Davy Mckee Ltd Process
US5679789A (en) 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
PT86631B (pt) 1987-01-29 1992-01-31 Beecham Group Plc Processo para a preparacao de uma nova forma cristalina de clavulanato de potassio
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT399155B (de) 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB2298201B (en) 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
DE69618045D1 (de) 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ZA975198B (en) 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
CN1238776A (zh) 1996-11-11 1999-12-15 吉斯特-布罗卡迪斯有限公司 制备棒酸盐和酯的方法

Also Published As

Publication number Publication date
DK26093A (da) 1993-09-11
AT400033B (de) 1995-09-25
FI931032A0 (fi) 1993-03-09
SE9300758L (sv) 1993-09-11
ES2058029A1 (es) 1994-10-16
IE70926B1 (en) 1997-01-15
HK42696A (en) 1996-03-22
AU3407093A (en) 1993-09-16
DE4307422A1 (de) 1993-09-30
US20030203886A1 (en) 2003-10-30
TW364907B (en) 1999-07-21
CY1995A (en) 1997-09-05
US20030022882A1 (en) 2003-01-30
ES2058029B1 (es) 1995-05-01
DK26093D0 (da) 1993-03-09
JP2817563B2 (ja) 1998-10-30
GR1002329B (el) 1996-05-15
NO930829L (no) 1993-09-13
CN1150153A (zh) 1997-05-21
ITRM930147A0 (it) 1993-03-10
CN1079743A (zh) 1993-12-22
GB2264944A (en) 1993-09-15
JPH1067785A (ja) 1998-03-10
AU659282B2 (en) 1995-05-11
IT1261213B (it) 1996-05-09
FR2688506A1 (fr) 1993-09-17
FI101965B1 (fi) 1998-09-30
FR2688506B1 (fr) 1995-06-23
USH2158H1 (en) 2006-06-06
FI931032A (fi) 1993-09-11
ITRM930147A1 (it) 1994-09-10
FI101965B (fi) 1998-09-30
NO301372B1 (no) 1997-10-20
CH685054A5 (de) 1995-03-15
GR930100090A (el) 1993-11-30
GB9304704D0 (en) 1993-04-28
US20010036940A1 (en) 2001-11-01
NL9300430A (nl) 1993-10-01
NO930829D0 (no) 1993-03-08
CN1145906A (zh) 1997-03-26
GB2264944B (en) 1995-09-06
ATA47292A (de) 1995-01-15
DE4307422B4 (de) 2004-11-25
SE9300758D0 (sv) 1993-03-08
JPH0641143A (ja) 1994-02-15
US20020072513A1 (en) 2002-06-13
IE930172A1 (en) 1993-09-22
CN1045604C (zh) 1999-10-13

Similar Documents

Publication Publication Date Title
US4757138A (en) Process for producing etoposide
SE508043C2 (sv) Förfarande för framställning och användning av 2-amino-2,4,4- trimetylpentansaltet av klavulansyra som mellanprodukt vid framställning av farmaceutiskt godtagbara salter av klavulansyra
CZ54495A3 (en) Process for preparing and/or purification of clavulanic acid
EP1863822A1 (en) An improved process for the preparation of cefixime
CA1103264A (en) Purification of pseudomonic acid
EP0005614B1 (en) Lithium pseudomonate, process for its isolation and its hydrolysis
JPS626718B2 (zh)
US5726170A (en) Clavulanic acid salts
US3634417A (en) Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
EP0099297B1 (fr) Nouveaux dérivés des céphalosporines, leur procédé de préparation et médicaments antibiotiques contenant lesdits dérivés
US3634416A (en) Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US3281461A (en) Process for preparing penicillamine
PL188634B1 (pl) Sposób wytwarzania potasowej soli kwasu klawulanowego
US4168375A (en) Process for the recovery of cephalosporin C and derivatives thereof
EP0311521B1 (fr) Dérivés des céphalosphorines à pharmacocinétique améliorée, procédé pour leur préparation, compositions pharmaceutiques les contenant et intermédiaire de synthèse
US3968154A (en) Method of producing penicillamine
JPH0753524A (ja) ２−ブチル−４−クロロイミダゾール−５−カルバルデヒドの製造法
JPS59152346A (ja) 光学活性２−（６−メトキシ−２−ナフチル）プロピオン酸の製造法
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
US2636897A (en) Nu-oxyalkyl-p-aminobenzoate compounds
JPS6037117B2 (ja) ６−アミノペニシラン酸誘導体の製法
IES65748B2 (en) Process for the separation of the optical antipodes of racemic phenyl-(2-Pyridyl)-dimethylpropylamines
JPH0156072B2 (zh)
HU190017B (hu) Eljárás primicin elkülönítésére és tisztítására

Legal Events

Date Code Title Description
NUG Patent has lapsed